Investing into Oncology: Who, What and Where?

Tuesday, May 5, 2020 | 12:45 – 2:00 pm


  • Mark Simon, Partner and Co-Founder, Torreya


  • Michele Cleary, PhD, CEO, The Mark Foundation for Cancer Research
  • Michael Gladstone, Principal, Atlas Venture
  • Michael G. King Jr., Entrepreneur in Residence, Fortress Biotech Inc.
  • Christoph Lengauer, PhD, MBA, Partner, Third Rock Ventures
  • Vanessa Lucey, PhD, MBA, Director, CRI Venture Fund & Clinical Accelerator, Cancer Research Institute
  • Bibhash Mukhopadhyay, PhD, Principal, NEA
  • Michal Silverberg, MBA, Managing Director, Novartis Venture Funds